Results 81 to 90 of about 179,970 (275)

The Relationship Between the FRAX Tool and Bone Turnover Markers in Postmenopausal Osteoporosis

, 2013
Aim: In this study, we aimed to show the correlation between the ten-year fracture risk, calculated with FRAX and bone turnover markers (BTM) in a group of postmenopausal women with osteoporosis.
Murat Uludağ, Ülkü Akarırmak, Murat Bolayırlı   +2 more
core   +1 more source

Diffuse cranial vault hyperostosis associated with long‐term antiepileptic therapy: Autopsy findings and differential diagnostic considerations

Journal of Forensic Sciences, EarlyView.
Abstract Diffuse cranial vault hyperostosis is an uncommon finding and may present a diagnostic challenge in clinical and forensic practice. We report the case of a 53‐year‐old woman with a long‐standing history of epilepsy treated with phenytoin and sodium valproate who collapsed at home suddenly and died despite resuscitative efforts.
Maria Piagkou, Athina Tousia, George Triantafyllou, Dimitrios Vlachodimitropoulos, Samer Al Besher, Panagiotis Manolarakis‐Papadopoulos, Alexandros Samolis, Stavroula Papadodima   +7 more
wiley   +1 more source

Systemic Therapy Management Strategies for Early‐Stage Breast Cancer in Australia

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Advances in systemic therapy for early‐stage breast cancer in Australia highlight genomic‐guided decisions, subtype‐specific strategies, and emerging targeted and immunotherapies, shaping personalized and de‐escalated treatment approaches. ABSTRACT Breast cancer is the most common cancer among Australian women, with early‐stage disease (Stages I, II ...
Nicholas Zdenkowski, Rachel Dear, Sanjeev Kumar, Hilary Martin, Dhanusha Sabanathan, Stephen J. Luen, Belinda Yeo   +6 more
wiley   +1 more source

Is Passive Smoking a Risk Factor for Postmenopausal Osteoporosis? - Original Investigation

, 2009
Aim: We aimed to show whether or not passive smoking is a risk factor for postmenopausal osteoporosis. Material and Methods: 250 postmenopausal women between the ages 40-65, who have not had menstruated for at least one year, had FSH>40mIU/ml, have not ...
Osman Altunbayrak, Deniz Palamar, Güler Ateşer, Ülkü Akarırmak, Merih Sarıdoğan   +4 more
core  

It's not “just aging”: Reframing postmenopausal urological dysfunction in primary care

UroPrecision, EarlyView.
Maya Aldeeb, Ibrahim A. Khalil
wiley   +1 more source

Bone Health and Aging in Klinefelter Syndrome

Andrology, EarlyView.
ABSTRACT Klinefelter syndrome (KS) is typically diagnosed in young adults, but advances in prenatal testing have led to its recognition at a much earlier age. Conversely, diagnosis in late adulthood remains uncommon, but still occurs. Independently from the age at diagnosis, KS individuals now receive more accurate and tailored care management than in ...
Filippo Vignali, Daniele Renda Livraghi, Francesco Costantino, Sara De Vincentis, Vincenzo Rochira   +4 more
wiley   +1 more source

Evaluation of Serum Osteocalcin and Osteopontin Levels as Bone Biochemical Markers in Postmenopausal Women.

مجله كليه طب الكندي, 2013
Background: Studies discussing the correlation between biochemical markers of bone turnover and the diagnosis of osteoporosis in postmenopausal Iraqi women are rare.
Kisma M Turki, Mohammed H Al-Osami, Nawar S Mohammed   +2 more
doaj  

Daily supplement of sesame oil prevents postmenopausal osteoporosis via maintaining serum estrogen and aromatase levels in rats

Scientific Reports
Estrogen deficiency is one of the main causes of postmenopausal osteoporosis in elderly women. Hormone replacement therapy has been employed to manage postmenopausal osteoporosis; however, it has raised concerns related to heart attacks and breast cancer.
Che-Chia Hsu, Po-Yen Ko, Ting-Hsien Kwan, Ming-Yie Liu, I.-Ming Jou, Chi-Wei Lin, Po-Ting Wu   +6 more
doaj   +1 more source

Importance of Biochemical Markers in Postmenopausal and Senile Osteoporosis

, 2002
Recently, the biochemical markers are widely used in order to evaluate the bone turnover. This study was planned to investigate the role of biochemical markers and Bone Mineral Density(BMD) in postmenopausal (PMO) and senile osteoporosis (SO) patients ...
Deniz Evcik, Mustafa Serteser
core  

Menopausal status at the age of 46: Its association with depressive and anxiety symptoms and morbidity in women—A northern Finland birth cohort 1966 study

Acta Obstetricia et Gynecologica Scandinavica, EarlyView.
Women who are perimenopausal or menopausal at age 46 have a higher risk of anxiety and depressive symptoms than premenopausal women. Early‐onset menopause highlights the need for mental health support during and after the menopausal transition. Abstract Introduction The incidence of several morbidities increases during the menopausal transition ...
Tiia Saarinen, Susanna M. Savukoski, Paula Pesonen, Jouko Miettunen, Maarit Niinimäki   +4 more
wiley   +1 more source